Health care utilization and medical costs in new users of once-weekly GLP-1 RAs compared with new users of DPP-4 is among individuals with type 2 diabetes and atherosclerotic cardiovascular disease
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要